版本:
中国

BRIEF-Acasti Pharma Q2 loss per share $0.22

Oct 11 Acasti Pharma Inc

* reports second quarter 2017 financial results

* Qtrly loss per share $0.22

* if co does not raise additional funds, there exists uncertainty that casts substantial doubt about ability to continue as going concern

* Management has reasonable expectation that corporation will be able to raise additional funds Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐